Use of fluoroquinolones in children;Les fluoroquinolones chez l'enfant

Medecine Tropicale

Volumn 62, Issue 2, 2002, Pages 185-192

  Gendrel, D ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Antibiotics; Children; Fluoroquinolones; Salmonellosis; Shigellosis; Side effects

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTHROPATHY; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CANADA; CHILD; CYSTIC FIBROSIS; DRUG MECHANISM; ENTEROBACTERIACEAE; FEBRILE NEUTROPENIA; FRANCE; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE DEFICIENCY; LUNG INFECTION; MENINGITIS; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; NEWBORN INFECTION; OTITIS; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; RISK BENEFIT ANALYSIS; SALMONELLOSIS; SHIGELLOSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; URINARY TRACT INFECTION;

CHILD; CYSTIC FIBROSIS; DYSENTERY, BACILLARY; FLUOROQUINOLONES; HUMANS; INFANT, NEWBORN; INFECTION; JOINT DISEASES; MENINGITIS, BACTERIAL; MYCOBACTERIUM INFECTIONS; SALMONELLA INFECTIONS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; PNEUMOCOCCUS; SALMONELLA; STREPTOCOCCUS PNEUMONIAE;

EID: 0036937983     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. CONROY S, CHOONARA I, IMPICCIATORE P et Coll - Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79-82.
2. ARADOTTIR E, YOGEV R - The use of fluoroquinolones in pediatrics: a reassessment. Sem Pediatr Infect Dis 1999; 10: 31-37.
3. ACAR JF, GOLDSTEIN FW - Trends in bacterial resistance to fluoroquinolones. Clin Inf Dis 1997; 24: S67-S73.
4. HOOPER DC - New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis 2000; 30: 243-254.
5. GARAU J, XERCAVINS M, RODRIGUEZ-CARBALLEIRA M et Coll - Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-2741.
6. PROSSER BLT, BESKID G - Multicenter in vitro comparative study of fluoroquinolones in 25.129 gram-positive and gram-negative clinical isolates. Diagn Microbiol Infect Dis 1995; 21: 33-45.
7. GOLDSTEIN FW, ACAR JF - Epidemiology of quinolone resistance: Europe and North and south America. Drugs 1995; 49 Suppl 2: 36-42.
8. BROWN JC, SHANAHAN PMA, JESUDASON MV et Coll - Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multiresistant Salmonella typhi in India. J Antimicrob Chemother 1996; 37: 891-900.
9. WAIN J, HOA NTT, CHINH NT et Coll - Quinolone-resistant Salmonella typhi in Vietnam: molecular basis if resistance and clinical response to treatment. Clin Infect Dis 1997; 25: 1404-1410.
10. HAKANEN A, SIITONEN A, KOTILAINEN P, HUOVINEN P - Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother 1999; 43: 145-148.
11. MOLBAK K, BAGGESEN DL, AARESTRUP FM et Coll - An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 1999; 341: 1420-1425.
12. WIUFF C, MADSEN M, BAGGESEN DL, AARESTRUP FM - Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark. Microb Drug Resist 2000; 6: 11-17.
13. CHEN DK, MCGEER A, DE AZAVEDO JC, LOW DE - Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341: 233-239.
14. PELTOLA H, VAARALA M, RENKONEN V et Coll - Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob Agents Chemother 1992; 36: 1086-1090.
15. CAPPARELLI E, LECRETA F, BLUMER J et Coll - Single dose safety and pharmacokinetics (PK) of oral gatifloxacin in pediatric patients. Abstract 15, 40th ICAAC, September 17-20, 2000, Toronto, Ontario, Canada.
16. CHYSKY V, KAPILA K, HULLMANN R et Coll - Safety of ciprofloxacin in children: Worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991; 19: 289-296.
17. HAMPEL MD, HULLMANN MS, SCHMIDT AD - Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate usesafety report. Pediatr Infect Dis J 1997; 16: 127-129.
18. LUMBIGANON P, PENGSAA K, SOOKPRANEC T - Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatr Infect Dis J 1991; 10: 619-620.
19. AUJARD Y, GENDREL D - Les quinolones en pédiatrie. Flammarion ed, Paris, 1994.
20. JACQZ-AIGRAIN E, BRUN P, BENNASR S, LOIRAT C - Side effects of pefloxacin in idiopathic nephrotic syndrome. Lancet 1993; 342: 438-439.
21. BEDU A, NAAR I, FARNOUX C et Coll - Hypertension intracrânienne chez un nouveau-né traité par quinolones. Presse Med 1998; 27: 1140-1142.
22. JOB-DESLANDRES C - Toxicité articulaire des quinolones. In «AUJARD Y, GENDREL D - Les quinolones en pédiatrie». Flammarion ed, Paris, 1994, pp 111-115.
23. LIPSKY BA, BAKER CA - Fluoroquinolones toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999; 28: 352-364.
24. BURKHARDT JE, WALTERSPIEL JN, SCHAAD UB - Quinolone arthropathy in animals versus children. Clin Infect Dis 1997; 25: 1196-1204.
25. MENSCHIK M, NEUMULLER J, STEINER CW et Coll - Effects of ciprofloxanin and floxacin on adult human cartilage in vitro. Antimicrob Agents Chemother 1997; 41: 2562-2565.
26. SCHAAD UB, WEDGWOOD-KRUCKO J - Nalicixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 1987; 15: 165-168.
27. NUUTINEN M, TURTINEN J, UHARI M - Growth and joint symptoms in children treated with nalidixic acid. Pediatr Infect Dis J 1994; 13: 798-800.
28. KUHN R, KANGA J, PALMEJAR A et Coll - Retropective review of ciprofloxacin for the treatment of acute pulmonary exarcebation in the pediatric CF patient. Pediatr Pulmonol 1990; 5: 246S-252S.
29. WARREN RW - Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 1997; 16: 118-122.
30. MEYBOOM RHB, OLSSON S, KNOL A et Coll - Achilles tendinitis induced by pefloxacin and other fluoroquinolone derivates. Pharmacoepidemiology Drug Safety 1994; 3: 185-189.
31. JICK S - Ciprofloxacin safety in pediatric population. Pediatr Infect Dis J 1997; 16: 130-134.
32. SEGEV S, YANIV I, HAVERSTOCK D, REINHART H - Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review. Clin Infect Dis 1999; 28: 299-308.
33. SCHAAD UB, ABDUS SALAM M, AUJARD Y et Coll - Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995; 14: 1-9.
34. KUHN R, KANGA J, PALMEJAR A et Coll - Retropective review of ciprofloxacin for the treatment of acute pulmonary exarcebation in the pediatric CF patient. Pediatr Pulmonol 1990; 5: 246S-2452S.
35. FREIFELD A, PIZZO P - Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients. Pediatr Infect Dis J 1997; 16: 140-146.
36. HUGHES WT, ARMSTRONG D, BODEY GP et Coll - 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 551-573.
37. GREEN SDR, ILLUNGA SM, CHEESBROUGH JS et Coll - The treatment of neonatal meningitis due to gram negative bacilli with ciprofloxacine: Evidence of satisfactory penetration into the CSF. J Infect 1993; 26: 253-256.
38. GOEPP JG, LEE CCK, ANDERSON T et Coll - Use of ciprofloxacin in an infant with ventriculitis. J Pediatr 1992; 131: 303-305.
39. LE HUIDOUX P, BINGEN E, BEDU A, AUJARD Y - Méningites néonatales: place des fluoroquinolones. Journées Parisiennes de Pédiatrie. Flammarion ed, 1999, Paris, pp 15-26.
40. GOUYON JB, BENOIT A, BETREMIEUX P et Coll - Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants. Pediatr Infect Dis J 1994; 13: 840-841.
41. FRADIS M, BRODSKY A, BEN-DAVID J et Coll - Chronic otitis media treated topically with ciprofloxacin or tobramycin. Arch Otolaryngol Head Neck Surg 1997; 123: 1057-1060.
42. LANG R, GOSHEN S, RAAS-ROTHSCHILD A et Coll - Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children. Pediatr Infect Dis J 1992; 11: 925-929.
43. FUJI R, MEGURO H, ARIMASU O et Coll - Evaluation of norfloxacin in the pediatric field. Jpn Antibiot 1990; 43: 181-215.
44. VAN WIJK JAE, DE JONG TPVM, VAN GOOL JD et Coll - Using quinolones in urinary tract infections in children. Adv Antimicrob Antineopl Chemother 1992; 11: 157-161.
45. DUTTA P, RASAILY R, SAHA MR et Coll - Ciprofloxacin for the treatment of severe typhoid fever in children. Antimicrob Agents Chemother 1993; 37: 1197-1199.
46. GREEN SD, MEWA R, ILLUNGA F et Coll - An open study of ciprofloxacin for the treatment of proven or suspected extra-intestinal salmonellosis in African children. Eur J Clin Microbiol Infect Dis 1993; 11: 181-187.
47. LEIBOVITZ E, JANCO J, PIGLANSKY L et Coll - Oral ciprofloxacin vs. Intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J 2000; 19: 1060-1067.
48. GENDREL D, RAYMOND J, LE GALL MA et Coll - Use of pefloxacin after failure of initial antibiotic treatment in children with severe salmonellosis. Eur J Clin Microb Infect Dis 1993; 12: 209-211.
49. J RAYMOND, F MOULIN, J BADOUAL, D GENDREL - Eradication of Convalescent Salmonella Carriage in Children Using Two Oral Doses of Pefloxacin. Eur J Clin Microb Infect Dis 1994; : 307-310.
50. LOLEKHA S, VIBULBANDHITKIT S, POOYNARIT P - Response to antimicrobial therapy for shigellosis in Thailand. Rev InfectDis 1991; 13: S342-346
51. BHATTACHARYA SK, BHATTACHARYA MD, DUTTA D et Coll - Double-bind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediatr 1997; 86: 319-320.
52. GENDREL D, JL MORENO, NDUWIMANA M et Coll - One-dose treatment with pefloxacin for infection due to multidrug-resistant shigella dysenteriae type 1 in Burundi. Clin Infect Dis 1997; 24: 83.
53. BENNISH MI, SALAM MA, KAHN WA et Coll - Treatment of shigellosis: III. Comparison of one and two dose ciprofloxacin with standard 5 day treatment. A randomized, blinded trial. Ann Intern Med 1992; 117: 727-734.
54. GUYON P, CASSEL-BERAUD AM, RAKOTONIRINA G, GENDREL D - Short treatment with pefloxacin in madagascan children with shigellosis due to multiresistant organisms. Clin Inf Dis 1994; 19: 1172-1173.
55. ALANGADEN GJ, LERNER ST - The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis 1997; 25: 1213-1221.
56. th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, September 1996.
57. SAEZ-LLORENS X, FERIS JM, KLUGMAN KP - Use of quinolone in children with bacterial meningitis (BM). A comparative study of trovofloxacin and ceftriaxone ( vancomycin. Abstract 828, 40th ICAAC, September 17-20, 2000, Toronto, Ontario, Canada.
58. GILJA OH, HALSTENSEN A, DIGRANES A et Coll - Use of singledose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother 1993; 37: 2024-2027.